CalciMedica is trading at $0.44, down 6.1%, after announcing a 1-for-5 reverse stock split.

  • The announcement followed a 20.00% decline on August 27; company news is the clearest catalyst amid biotech weakness and hawkish Fed concerns.
  • The split is effective at 5:00 p.m. ET on August 28, 2026; split-adjusted trading begins August 31, 2026.
  • Authorized shares will fall from 500 million to 100 million; the move is intended to restore compliance with Nasdaq’s minimum bid-price requirement.